Does the evidence match the offer?
Ask for the study behind a treatment claim. Then ask what was actually studied and how it relates to the exact medicine being proposed.
U.S. care context: September 2026.
Ask what the study can tell you
Keep the claim and the study together. Ask the prescriber to explain the connection without relying on a paper’s title.
- Was the study in people, or was it an early test in a lab or in animals?
- Did it study this exact product or only an ingredient?
- What did it measure, and does that relate to my goal?
- What did it leave unanswered?
- How much is still unknown about whether this treatment would help me?
Ask what “the same results” is based on
A compounded medicine is made to order for a patient.
The Food and Drug Administration (FDA) checks the evidence about a medicine and the uses named for it.
FDA says in September 2026 that it is misleading to claim a compounded medicine has been proven to match an approved product’s results.
- Is the evidence for the finished product you propose?
- Are you drawing a conclusion from a different medicine?
- Can you explain that gap in plain words?
Why make this medicine to order for you?
As of September 2026, ordinary pharmacies cannot regularly make medicines that closely copy ready-made products already on the market.
An exception may apply when the prescriber decides a particular patient would experience an important difference from a change to the medicine.
A lower price by itself does not qualify for that exception.
- What change to the medicine do I need, and why?
- Where is that reason recorded?
- Why would a ready-made option not meet that need?
Advice and a changed rule are separate steps
As of September 2026, FDA has no published record of the votes from its July 2026 peptide compounding committee meeting.
A vote from this committee provides advice and leaves the rules unchanged. FDA has a list of extra ingredients that pharmacies may use in made-to-order medicines. Changing that list requires a separate process that lets the public comment.
- Which rule lets the pharmacy make this exact medicine?
- Can you show the rule rather than a headline about a meeting?
- What is still undecided?
Ask what a report proves
FDA says in September 2026 that a problem report cannot establish whether the medicine was the cause or how often the problem occurs.
- What kind of evidence supports this claim?
- Does it describe a reported concern or a proven cause?
- What does the prescriber know about this exact product?
A short reading list
Food and Drug Administration (FDA) · U.S. medicine review agency
FDA examples of misleading compounding claims
The examples include claims that a compounded medicine gives the same result as an approved one.
Use it to turn broad wording into a question about the exact product.
Food and Drug Administration (FDA) · U.S. medicine review agency
FDA papers from the peptide committee meeting
As of September 2026, the meeting page has papers to read but no published official notes, written record of what was said, or vote results.
A meeting page does not itself settle whether the pharmacy is allowed to make a medicine.
Food and Drug Administration (FDA) · U.S. medicine review agency
How FDA explains reports of problems
A report sent to FDA does not prove that a medicine caused the problem.
The number of reports does not tell you how likely you are to have the problem.